A) Disruption of cell membrane integrity B) Inhibition of protein synthesis C) Inhibition of DNA replication D) Inhibition of cell wall synthesis
A) Ribosomes B) Peptidoglycan layer of bacterial cell walls C) Cell membrane lipids D) Nucleoid region
A) Synthesize nucleic acids B) Transport nutrients across the cell membrane C) Facilitate the final transpeptidation step in peptidoglycan synthesis D) Generate energy for the cell
A) Penicillin binding proteins (PBPs) B) Lipoproteins C) DNA polymerases D) Ribosomal proteins
A) Facilitates their binding to the active site of PBPs B) Enables them to inhibit ribosomal function C) Helps them to bind to DNA D) Allows them to penetrate the bacterial cell membrane
A) Arg75 B) Ser62 C) Glu100 D) Lys50
A) Enhancement of peptidoglycan synthesis B) Stimulation of bacterial cell division C) Prevention of the final crosslinking of the peptidoglycan layer D) Activation of bacterial DNA replication
A) Viruses B) Bacteria, including cyanobacteria, cyanelles, and chloroplasts of bryophytes C) Fungi D) Vascular plants
A) Inhibition of division B) No effect C) Disruption of photosynthesis D) Induction of cell death
A) Cell theory B) Theory of spontaneous generation C) Germ theory of disease D) Endosymbiotic theory
A) Absence of nutrients B) Presence of β-lactam antibiotics C) Build-up of peptidoglycan precursors D) High temperature
A) By increasing bacterial cell wall synthesis B) By promoting bacterial cell division C) By inhibiting bacterial DNA replication D) By causing the digestion of existing peptidoglycan without new production
A) Penicillinase B) Aminoglycoside acetyltransferase C) β-lactamase D) Methicillin-resistant enzyme
A) Protease inhibitors B) Reverse transcriptase inhibitors C) β-lactamase inhibitors such as clavulanic acid D) Integrase inhibitors
A) Bradycardia B) Hypertension C) Diarrhea D) Hyperglycemia
A) Approximately 5% B) Approximately 15% C) Approximately 2% or less D) Approximately 10%
A) Approximately 15% B) Less than 1% C) Approximately 10% D) Approximately 5%
A) Anaphylactic reaction B) Tzanck reaction C) Jarisch–Herxheimer reaction D) Serum sickness
A) The solubility of the β-lactam antibiotic B) The molecular weight of the β-lactam antibiotic C) Woodward's parameter (h) D) Cohen's parameter (c)
A) The solubility of the β-lactam antibiotic B) Woodward's parameter (h) C) The molecular weight of the β-lactam antibiotic D) Cohen's parameter (c)
A) Constant h values B) Higher h values C) Zero h values D) Lower h values
A) Constant c values B) Zero c values C) Higher c values D) Lower c values
A) 8-oxo-2'-deoxyguanosine lesions B) Double-strand breaks C) Thymine dimers D) Single-strand breaks
A) An amide bond B) A carboxylate group C) A hydroxyl group D) A β-lactam ring
A) Ceftriaxone/meropenem B) Amoxicillin/clavulanic acid C) Piperacillin/tazobactam D) Ceftriaxone/nitrocefin
A) An auxiliary ring with a carboxylate group B) An amide bond C) A hydroxyl group D) A β-lactamase inhibitor
A) Clavulanic acid B) Meropenem C) Amoxicillin D) Ceftriaxone
A) It affects the antibiotic's taste B) It determines the antibiotic's color C) It influences the antibiotic's solubility D) It is essential for the antibiotic's antimicrobial activity
A) Carbapenams B) Penems C) Oxapenams D) Penams
A) Isopenicillin N synthase (IPNS) B) β-lactam synthetase C) ACV synthetase (ACVS) D) Nonribosomal peptide synthetase
A) Monobactam B) Isopenicillin N C) Cephem D) Carbapenem
A) Isopenicillin N synthase (IPNS) B) ACV synthetase (ACVS) C) β-lactam synthetase D) Nonribosomal peptide synthetase
A) Position 1 B) Position 4 C) Position 5 D) Position 3
A) Monobactams B) Penems C) Cephems D) Carbapenems
A) Carbapenems B) Cephems C) Penams D) Monobactams
A) Monobactams B) Oxacephems C) Cephems D) Carbacephems
A) Cephems B) Oxacephems C) Monobactams D) Carbacephems
A) Carbapenems B) Cephems C) Monobactams D) Penems
A) Carbacephems B) Cephems C) Oxacephems D) Monobactams
A) Penems B) Carbapenams C) Oxapenams D) Penams |